Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.34 |
| ▸ | FPR2 | P25090 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939934 | 0.94 | FFAR4 (0.35) | FFAR4FPR2FFAR1CNR2ALOX5AP | |
| SCHEMBL11939798 | 0.91 | FFAR4 (0.36) | FFAR4FPR2FFAR1GPR119DGAT1 | |
| SCHEMBL12836492 | 0.90 | FEN1 (0.34) | FPR2CNR2ALOX5APFEN1 | |
| SCHEMBL12836034 | 0.90 | FEN1 (0.34) | FPR2CNR2ALOX5APFEN1 | |
| SCHEMBL12836496 | 0.90 | FPR2 (0.33) | FFAR4FPR2DGAT1CNR2FEN1 | |
| SCHEMBL12907337 | 0.88 | CNR2 (0.35) | FPR2FFAR1CNR2ALOX5APFEN1 | |
| SCHEMBL12223313 | 0.88 | ALOX5AP (0.33) | FPR2CNR2ALOX5APFEN1 | |
| SCHEMBL11942190 | 0.87 | PIM1 (0.33) | FFAR4DGAT1ALOX5APFEN1 | |
| SCHEMBL12836499 | 0.86 | FPR2 (0.33) | FPR2FFAR1CNR2 | |
| SCHEMBL10303237 | 0.86 | HTR2A (0.35) | FPR2FFAR1GPR119CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011033937-A1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | チッソ株式会社 (JP) | 2011-03-24 | — | — | WO | disclosed |